You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 294 No. 21, December 7, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Otolaryngology/ Head & Neck Surgery
 •Endocrine Disease of Head & Neck
 •Alert me on articles by topic

Evaluation and Treatment of Primary Hyperparathyroidism

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In the Clinical Crossroads discussing a patient with primary hyperparathyroidism, Dr Strewler1 did not mention the intake of thiazide diuretics in the differential diagnosis of hypercalcemia. This is particularly important in cases of suspected primary hyperparathyroidism in which thiazide therapy may have an impact on disease management.

Thiazide diuretics can increase serum calcium levels by complex mechanisms that include a decrease in urinary calcium excretion,2-3 enhancement of parathyroid hormone action,2-3 and possibly an increase in intestinal calcium absorption and bone resorption.4 In healthy persons with normal calcium homeostasis, the increase in serum calcium with thiazide intake is generally mild and transient, in the range of 0.5 to 1 mg/dL (0.12-0.25 mmol/L), lasting 4 to 6 weeks.3-4 However, in patients with underlying hyperparathyroidism, thiazide use typically uncovers or aggravates the hypercalcemia.3, 5 In this setting, overestimation of hypercalcemia as a result of thiazide intake may lead to unnecessary patient . . . [Full Text of this Article]

Nasser Mikhail, MD, MSc
nmikhail@ladhs.org
Department of Endocrinology

Dennis Cope, MD
Department of Medicine
Olive View-UCLA Medical Center
Sylmar, Calif


RELATED ARTICLES

Evaluation and Treatment of Primary Hyperparathyroidism
Andrew Grey, Mark Bolland, and Ian R. Reid
JAMA. 2005;294(21):2699-2700.
EXTRACT | FULL TEXT  

A 64-Year-Old Woman With Primary Hyperparathyroidism
Gordon J. Strewler
JAMA. 2005;293(14):1772-1779.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.